ICAN Attorneys Demand Answers on Bird Flu Vaccines

As bird flu (H5N1) continues to receive public attention regarding reported cases and controversial research, ICAN investigated the three U.S. licensed H5N1 vaccines. Our review raises serious concerns, including the use of toxic ingredients, serious adverse events, and defective clinical trials. ICAN’s attorneys have therefore issued FOIA requests for clinical trial records and all internal FDA and HHS communications regarding these vaccines.

Lead Counsel, Aaron Siri, Esq., lays out the details here.

Read ICAN's Legal Update here: https://icandecide.org/press-release/ican-attorneys-demand-answers-on-bird-flu-vaccines/